Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| Sanofi SAN.PA | Pharmaceuticals: Major | $113B | +18% | +14% | +15% | 27% | 9.6× |
| EssilorLuxottica EL.PA | Medical Specialties | $101B | +36% | +12% | +8% | 12% | 26.6× |
| Sartorius Stedim Biotech DIM.PA | Medical Specialties | $24.7B | +9% | +38% | +4% | 19% | 45.5× |
| Ipsen IPN.PA | Pharmaceuticals: Major | $14.7B | +12% | -4% | +14% | 30% | 10.9× |
| bioMerieux BIM.PA | Medical Specialties | $12.4B | +16% | +29% | -3% | 15% | 20.9× |
| Abivax ABVX.PA | Pharmaceuticals: Other | $7.58B | 0% | -25% | n/a | n/a | n/a |
| Virbac VIRP.PA | Biotechnology | $3.38B | +14% | +5% | +4% | 15% | 17.2× |
| Emeis EMEIS.PA | Medical/Nursing Services | $1.94B | +9% | -30% | +4% | 3% | n/a |
| Nanobiotix NANO.PA | Pharmaceuticals: Major | $1.54B | +32% | -42% | -77% | -392% | n/a |
| Clariane CLARI.PA | Medical/Nursing Services | $1.40B | +8% | -20% | +1% | 6% | 8.6× |
| Vetoquinol VETO.PA | Pharmaceuticals: Major | $1.17B | +17% | +22% | -1% | 15% | 15.8× |
| MedinCell MEDCL.PA | Pharmaceuticals: Major | $1.15B | +14% | -1% | -23% | -131% | n/a |
| Ramsay Generale de Sante GDS.PA | Hospital/Nursing Management | $1.09B | -11% | -15% | +3% | 4% | n/a |
| Inventiva IVA.PA | Biotechnology | $912M | +21% | -29% | -100% | -307,063% | n/a |
| DBV Technologies DBV.PA | Pharmaceuticals: Major | $633M | +6% | -47% | n/a | n/a | n/a |
| Genfit GNFT.PA | Biotechnology | $593M | +27% | +19% | +28% | -130% | 79.3× |
| Valneva VLA.PA | Biotechnology | $534M | +1% | -2% | -27% | -87% | n/a |
| Boiron BOI.PA | Pharmaceuticals: Other | $391M | +12% | -31% | -2% | 5% | 9.7× |